Biosurgery Global Market Report 2024

Description

“Biosurgery Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosurgery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosurgery? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The biosurgery market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Bone-Graft Substitutes; Soft-Tissue Attachments; Hemostatic Agents; Surgical Sealants and Adhesives; Adhesion Barriers; Staple Line Reinforcement
2) By Source: Natural or Biologics Products; Synthetic Products
3) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Gynecological Surgery; Other Applications
4) By End-User: Hospitals; Clinics; Other End-Users
Companies Mentioned: Baxter International Inc.; B. Braun SE; Becton, Dickinson and Company; Hemostasis LLC; Integra LifeSciences Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Biosurgery involves utilizing live maggots to remove dead tissue, minimize infection risks, and accelerate wound healing. This field encompasses semi-synthetic, synthetic, or natural materials that aid in the recuperation of surgical incisions and tissue regeneration.

Primary biosurgery products include bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple line reinforcement. Bone graft substitutes are materials, natural or synthetic, used to fill bone voids and facilitate bone mending. These products stem from natural or biological sources as well as synthetic origins. They find application in orthopedic, general, neurological, cardiovascular, gynecological surgeries, and others, catering to end-users such as hospitals, clinics, and similar facilities.

The biosurgery market research report is one of a series of new reports from The Business Research Company that provides biosurgery market statistics, including biosurgery industry global market size, regional shares, competitors with a biosurgery market share, detailed biosurgery market segments, market trends and opportunities, and any further data you may need to thrive in the biosurgery industry. This biosurgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biosurgery market size has grown strongly in recent years. It will grow from $14.01 billion in 2023 to $15.18 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The expansion witnessed during the historical period can be linked to the upsurge in surgical interventions, escalation of chronic ailments, the expanding demographic of elderly individuals, a trend favoring biodegradable products, alterations in regulations, and the reception of approvals.

The biosurgery market size is expected to see strong growth in the next few years. It will grow to $20.87 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The projected expansion in the upcoming period can be credited to progress in tissue engineering, an increase in minimally invasive techniques, a concentrated effort on regenerative medicine, a transition towards biologics, and the evolving needs of an aging population. Key trends anticipated in the forecast period encompass the surge in minimally invasive procedures, an uptick in cosmetic and plastic surgeries, a heightened focus on stem cell therapies, advancements in wound care, and the evolution of biodegradable products.

The biosurgery market is poised for growth, primarily driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for a year or longer and requiring ongoing medical care, significantly impact individuals' health, restricting daily activities. In the U.S., chronic diseases such as diabetes, cancer, and heart disease are leading causes of death and disability. Biosurgery plays a crucial role in managing chronic wounds by eliminating dead tissue, reducing infection risk, and expediting the healing process. For example, in March 2022, the Australian Bureau of Statistics reported that 78.6% of Australians suffered from at least one chronic illness, affecting over half of the population. The rise in chronic diseases is a key factor propelling the growth of the biosurgery market.

A significant factor contributing to the growth of the biosurgery market is the increase in the number of accidents. Accidents, unforeseen events causing harm or injury, occur in various settings such as daily life, workplaces, transportation, and sports. Biosurgery is utilized in accident scenarios to mitigate blood loss, facilitate effective coagulation, and promote wound healing in traumatic situations, injuries, or surgical operations. In 2022, the Department of Infrastructure, Transport, Regional Development, and Communications in Australia reported 1,194 fatal traffic accidents, indicating a 5.8% increase over the previous year. The growth in accident numbers is driving the adoption of biosurgery for effective wound management.

A notable trend in the biosurgery market is the emphasis on product innovations by major companies to strengthen their market position. For instance, Aroa Biosurgery, a New Zealand-based manufacturer of medical and surgical products, introduced Myriad Morcells in April 2021. Myriad Morcells, a Myriad Matrix morcellized (powder) configuration, enhances interaction with uneven wound beds. It delivers biologically significant extracellular matrix (ECM) proteins to kick-start the healing process. Myriad Matrix, a multi-layered ECM graft with high volume and surface area, leverages Aroa's ECM bioscaffold technology, incorporating essential secondary chemicals and persistent vascular channels to support the formation of new tissue. Product innovations such as these contribute to the competitiveness and growth of companies in the biosurgery market.

Prominent companies in the biosurgery market are increasingly adopting a strategic partnership approach to enhance their capabilities and expand their market presence. Strategic partnerships involve leveraging the strengths and resources of collaborating companies for mutual benefits and success. In a notable example, Biocomposites Ltd., a UK-based manufacturing company specializing in calcium compound solutions for bone and soft tissue regeneration and repair, entered into an agreement with Zimmer Biomet Holdings Inc. in March 2022. Under this agreement, Biocomposites exclusively sells genex Bone Graft Substitute in the US orthopedic market. Genex Bone Graft Substitute is a biphasic composite with excellent purity, precisely developed to balance osteoconductive scaffold toughness and persistence in the body, facilitating optimal bone architecture rebuilding. The partnership includes enhancements for the US market, incorporating a new closed-mixing method to save preparation time and extend working time. It also offers a broader range of delivery options, enabling surgeons to inject, shape, or prepare beads according to their preferred approach.

In December 2021, Becton, Dickinson (BD) and Company, a US-based medical technology company, acquired Tissuemed Ltd., for an undisclosed amount. This acquisition enables BD to strengthen Tissuemed's position as a leader in the rapidly expanding global market for sealant technology. Tissuemed, based in the UK, is a medical technology company specializing in the development of tissue-based therapeutic devices and bioadhesive films used in biosurgery. Through strategic partnerships and acquisitions, major companies are actively shaping the landscape of the biosurgery market, ensuring competitiveness and a broader reach in the evolving healthcare landscape.

Major companies operating in the biosurgery market report are Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., CryoLife Inc., CSL Limited, Pfizer Inc., Zimmer Biomet Holdings Inc., Kuros Biosciences AG, Orthofix Medical Inc., Smiths & Nephew plc, Medtronic plc, Stryker Corp., Cyrolife Inc., Betatech Medical, Tissue Regenix Group plc, Aroa Biosurgery Ltd., Anika Therapeutics Inc., Arthrex Inc., B Braun Surgical SA, Biom'Up SA, Boston Scientific Corporation, Coloplast Corp., Cook Medical Inc., Endo International plc, Genzyme Corporation, Takeda Pharmaceutical Company Limited, Cerus Corporation .

North America was the largest region in the biosurgery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biosurgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biosurgery market consists of revenues earned by entities by providing biosurgery services such as maggot therapy, transplantation, and autologous chondrocyte implantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The biosurgery market also includes sales of absorbable hemostats and surgical sealants which are used in providing biosurgery services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r10795

1. Executive Summary

2. Biosurgery Market Characteristics

3. Biosurgery Market Trends And Strategies

4. Biosurgery Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Biosurgery Market Size and Growth

5.1. Global Biosurgery Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Biosurgery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Biosurgery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biosurgery Market Segmentation

6.1. Global Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Bone-Graft Substitutes
Soft-Tissue Attachments
Hemostatic Agents
Surgical Sealants and Adhesives
Adhesion Barriers
Staple Line Reinforcement
6.2. Global Biosurgery Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Natural or Biologics Products
Synthetic Products
6.3. Global Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Gynecological Surgery
Other Applications
6.4. Global Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Other End-Users

7. Biosurgery Market Regional And Country Analysis

7.1. Global Biosurgery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Biosurgery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biosurgery Market

8.1. Asia-Pacific Biosurgery Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biosurgery Market

9.1. China Biosurgery Market Overview
9.2. China Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biosurgery Market

10.1. India Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biosurgery Market

11.1. Japan Biosurgery Market Overview
11.2. Japan Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biosurgery Market

12.1. Australia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biosurgery Market

13.1. Indonesia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biosurgery Market

14.1. South Korea Biosurgery Market Overview
14.2. South Korea Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biosurgery Market

15.1. Western Europe Biosurgery Market Overview
15.2. Western Europe Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biosurgery Market

16.1. UK Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biosurgery Market

17.1. Germany Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biosurgery Market

18.1. France Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biosurgery Market

19.1. Italy Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biosurgery Market

20.1. Spain Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biosurgery Market

21.1. Eastern Europe Biosurgery Market Overview
21.2. Eastern Europe Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biosurgery Market

22.1. Russia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biosurgery Market

23.1. North America Biosurgery Market Overview
23.2. North America Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biosurgery Market

24.1. USA Biosurgery Market Overview
24.2. USA Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biosurgery Market

25.1. Canada Biosurgery Market Overview
25.2. Canada Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biosurgery Market

26.1. South America Biosurgery Market Overview
26.2. South America Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biosurgery Market

27.1. Brazil Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biosurgery Market

28.1. Middle East Biosurgery Market Overview
28.2. Middle East Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biosurgery Market

29.1. Africa Biosurgery Market Overview
29.2. Africa Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biosurgery Market Competitive Landscape And Company Profiles

30.1. Biosurgery Market Competitive Landscape
30.2. Biosurgery Market Company Profiles
- 30.2.1. Baxter International Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. B. Braun SE
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Becton, Dickinson and Company
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Hemostasis LLC
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Integra LifeSciences Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Biosurgery Market Competitive Benchmarking

32. Global Biosurgery Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biosurgery Market

34. Biosurgery Market Future Outlook and Potential Analysis

34.1 Biosurgery Market In 2028 - Countries Offering Most New Opportunities
34.2 Biosurgery Market In 2028 - Segments Offering Most New Opportunities
34.3 Biosurgery Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer